Advertisement

Psychopharmacology

, Volume 118, Issue 1, pp 72–81 | Cite as

The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects

  • A. J. Cleare
  • A. J. Bond
Original Investigation

Abstract

In order to investigate the link between aggression and 5-HT, we looked at effects of changes in plasma tryptophan on healthy male subjects. Twenty-four with high trait aggression (H) and 24 with low (L) drank an amino acid mixture with (T+) or without (T−) trytophan. These caused plasma tryptophan enhancement and depletion, respectively, at 4.5 h. Group H subjects given T− became more angry, aggressive, annoyed, hostile and quarrelsome on subjective measures, whereas those given T+ responded in the opposite way. On a behavioural measure of aggression, group H subjects responded more aggressively after T− than T+. In contrast, there was no consistent effect on subjective or behavioural aggression in group L subjects. Feelings of well-being in group H were decreased by T− and increased by T+. In group L, T+ reduced feelings of well-being, possibly due to the sedative effect of tryptophan in this group, which correlated positively with plasma trytophan concentration. Changes in plasma tryptophan are probably followed by changes in central 5-HT turnover. We conclude that, in those with pre-existing aggressive traits, acute falls in central 5-HT can cause increased subjective and objective aggression, while rises can have the opposite effect. The absence of changes in a low aggressive group suggests that the primary effect may be on impulsivity, possibly mediated by 5-HT1a receptors, expressing underlying aggressive traits. The findings on mood changes provide support for earlier reports of a lowering of mood with tryptophan depletion.

Key words

Tryptophan depletion Tryptophan Aggression Mood Serotonin 5-HT1a receptor Impulsivity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Biggio G, Fadda F, Fanni P, Tagliamonte A, Gessa GL (1974) Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sci 14: 1321–1329Google Scholar
  2. Blackburn R (1993) Psychopathic disorder, personality disorders and aggression. In: Thompson C, Cowen P (eds) Violence, basic and clinical science Butterworth Heinemann, Oxford, pp 101–118Google Scholar
  3. Bond A, Lader MH (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211–218Google Scholar
  4. Bond A, Lader MH (1986a) A method to elicit aggressive feelings and behaviour via provocation. Biol Psychology 22: 69–79Google Scholar
  5. Bond A, Lader MH (1986b) The relationship between induced behavioural aggression and mood after the consumption of two doses of alcohol. Br J Addiction 81: 65–75Google Scholar
  6. Bond A, Lader MH (1988) Differential effects of oxazepam and lorazepam on aggressive responding. Psychopharmacology 95: 369–373Google Scholar
  7. Bond AJ, Silveira JC (1993) The combination of alprazolam and alcohol on behavioural aggression. J Stud Alcohol Suppl 11: 30–39Google Scholar
  8. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Goyer PC, Major LF (1979) Aggression in humans correlates with cerebrospinal fluid metabolites. Psychiatry Res 1: 131–139Google Scholar
  9. Brown GL, Ebert MH, Goyer PH, Jimerson DC, Klein WJ, Bunney WE, Goodwin FK (1982) Aggression, suicide and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 139: 741–746Google Scholar
  10. Brown CS, Kent TA, Bryant SG, Gevedon R, Campbell J, Felthous A, Barratt E, Rose R (1989) Blood platelet uptake of serotonin in episodic aggression. Psychiatry Res 27: 5–15Google Scholar
  11. Buss AH, Durkee A (1957) An inventory for assessing different kinds of hostility. J Consult Psychol 21: 343–349Google Scholar
  12. Chamberlain B, Ervin F, Pihl R, Young SN (1987) The effect of raising or lowering tryptophan levels on aggression in vervet monkeys. Pharmacol Biochem Behav 28[4]: 503–510Google Scholar
  13. Charney DS, Heninger GR, Reinhard JF, Sternberg DE, Hafstead KM (1982) The effect of intravenous tryptophan on prolactin and growth hormone and mood in normal subjects, Psychopharmacology 77: 217–222Google Scholar
  14. Checkley SA (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Pychol Med 10: 35–53Google Scholar
  15. Caccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989) Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 46: 587–599Google Scholar
  16. Colenda CC (1988) Buspirone in treatment of agitated demented patient. Lancet 1: 1169Google Scholar
  17. Cooper JR, Melcer I (1961) The enzymatic oxidation of tryptophan to 5-hydroxytryptophan in the biosynthesis of serotonin. J Pharmacol Exp Ther 132: 265–268Google Scholar
  18. Delgado P, Charney DS, Price LH (1993) Reply to Norden M, “Risk of tryptophan depletion following amino acid supplementation”. Arch Gen Psychiatry 50: 1000–1001Google Scholar
  19. Gedye A (1991) Buspirone alone or with serotonergic diet reduced aggression in a developmentally disabled adult. Biol Psychiatry 30: 88–91Google Scholar
  20. Gessa GL, Biggio G, Fadda F, Corsini GV, Tagliamonte A (1974) Effect of the oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism. J Neurochem 22: 869–870Google Scholar
  21. Giammanco S, Ernandes M, Lopez de Onate R, Paderni MA (1990) Short term diet of precooked corn meal almost lacking in tryptophan and interspecific rat-mouse aggressive behaviour. Arch Int Physiol Biochim 98[1]: 23–26Google Scholar
  22. Gibbons JL, Barr GA, Bridger WH, Liebowitz SF (1979) Manipulation of dietary tryptophan: effects on mouse killing and brain serotonin in the rat. Brain Res 169: 139–153Google Scholar
  23. Gibbons JL, Barr GA, Bridger WH, Liebowitz SF (1981)l-Tryptophan's effect on mouse killing, feeding, drinking, locomotion and brain serotonin. Pharmacol Biochem Behav 15: 201–216Google Scholar
  24. Golden RN, Gilmore JH, Corrigan MHN, Ekstrom RD, Knight BT, Garbutt JC (1991) Serotonin, Suicide, and aggression: Clinical studies. J Clin Psychiatry 52[12, supp]: 61–69Google Scholar
  25. Greenwood MH, Lader MH, Kantmeneni BD, Curzon G (1975) The acute effects of orall-tryptophan in human subjects. Br J Clin Pharmacol 2: 165–172Google Scholar
  26. Harrington MA, Zhong P, Garlow SJ, Ciaranello RD (1992) Molecular biology of serotonin receptors. J Clin Psychiatry 53 [10, supp]: 8–27Google Scholar
  27. Kantak KM, Hegstrand LR, Whitman J, Eichelman B (1980) Effects of dietary supplements and a tryptophan free diet on aggressive behaviour in rats. Pharmacol Biochem Behav 12: 173–180Google Scholar
  28. Keating J, Dratcu L, Lader M, Sherwood RA (1993) Measurement of plasma serotonin by high-performance liquid chromatography with electrochemical detection as an index of the in vivo activity of fluvoxamine. J Chromatogr 615: 237–242Google Scholar
  29. Kitahara M (1986) Dietary tryptophan ratio and homicide in western and southern Europe. J Orthomolec Med 1[1]: 13–16Google Scholar
  30. Kitahara M (1988) Dietary tryptophan ration and suicide in the United Kingdom, Ireland, the United States, Canada, Australia and New Zealand. Omega J Death Dying 18: 71–76Google Scholar
  31. Leathwood PD, Pollet P (1983) Diet-induced mood changes in normal populations. J Psychiatr Res 17: 147–154Google Scholar
  32. Levine (1988) Buspirone and agitation in head injury. Brain Injury 2: 165–187Google Scholar
  33. Lidberg L, Tuck JR, Asberg M, Scalia Tomba G-P, Bertilson L (1985) Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand 71: 230–236Google Scholar
  34. Lieberman HR, Corkin S, Spring BJ, Growdon JH, Wurtman RJ (1983) Mood, performance, and pain sensitivity: changes induced by food constituents. J Psychiatr Res 17: 135–145Google Scholar
  35. Lindgren T, Kantak K (1987) Effects of serotonin receptor agonists and antagonists on offensive aggression in mice. Aggress Behav 13: 87–96Google Scholar
  36. Linnoila M, Virkunnen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK (1983) Low cerebrospinal fluid 5-hydroxyin-dolacetic acid differentiates impulsive from non-impulsive aggressive behaviour. Life Sci 33: 2609–2614Google Scholar
  37. Miczek KA, Weerts E, Haney M, Tidey J (1994) Neurobiological mechanisms controlling aggression: pre-clinical developments for pharmacotherapeutic intervention. Neurosci Biobehav Rev 18: 97–110Google Scholar
  38. Modai I, Apter A, Meltzer M, Tyano S, Walevski A, Jerushalmy Z (1989) Serotonin uptake by platelets of suicidal and aggressive adolescent psychiatric inpatients. Neuropsychobiology 21: 9–13Google Scholar
  39. Morand C, Young SN, Ervin FR (1983) Clinical response of aggressive schizophrenics to oral tryptophan. Biol Psychiatry 18: 575–578.Google Scholar
  40. Moss HB, Yao JK, Panzak GL (1990) Serotonergic responsivity and behavioural dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry 28: 325–338Google Scholar
  41. Norden M (1993) Risk of tryptophan depletion following amino acid supplementation. Arch Gen Psychiatry 50: 1000Google Scholar
  42. O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan T (1992) Blunted prolactin responses tod-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry 160: 643–646Google Scholar
  43. Olivier B, Mos J, Van der Hayden J, Hartog J (1989) Serotonergic modulation of social interactions in isolated male mice. Psychopharmacology 97: 154–156Google Scholar
  44. Olivier B, Tulp M, Mos J (1991) Serotonergic receptors in anxiety and aggression: evidence from animal pharmacology. Hum Psychopharmacol 6 [suppl]: 73–78Google Scholar
  45. Ratey JJ, Sovner R, Mikkelson E, Chmielinski HE (1989) Buspirone therapy for maladaptive behaviour and anxiety in developmentally disabled persons. J Clin Psychiatry 50: 382–384Google Scholar
  46. Ratey JJ, Sovner R, Parks A, Rogentine K (1991) Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. J Clin Psychiatry 52: 159–162Google Scholar
  47. Rodgers RJ, Cooper SJ (1991) 5-HT-la agonists, 5-HT-3 antagonists and benzodiazepines: their comparative behavioural pharmacology. Wiley, ChichesterGoogle Scholar
  48. Roy A, Adinoff B, Linnoila M (1988) Acting out hostility in normal volunteers: negative correlation with levels of 5-HIAA in cerebrospinal fluid. Psychiatry Res 24: 187–194Google Scholar
  49. Sanchez C, Arnt J, Hyttel J, Moltzen EK (1993) The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice. Psychopharmacology 110: 53–59Google Scholar
  50. Shea M, Douglas L, Meach J (1991) The interaction of dominance status and supplemental tryptophan on aggression in gallus domesticus males. Pharmacol Biochem Behav 38: 587–591Google Scholar
  51. Smith SE, Pihl RO, Young SN Ervin FR (1986) Elevation and reduction of plasma tryptophan and their effects on aggression and perceptual sensitivity in normal males. Aggress Behav 12: 393–407Google Scholar
  52. Spielberger CD, Gorusch RL, Lushene RE (1970) Manual for the state-trait anxiety inventory (self evaluation questionnaire). Consulting Psychologists Press, Palo Alto, CaliforniaGoogle Scholar
  53. Spielberger CD, Jacobs G, Russell S, Crane RS (1983) Assessment of anger: the state-trait anger scale. In: Butcher JN Spielberger CD (eds) Advances in personality assessment, vol 2. Lawrence Erlbaum Hillsdale, New Jersey and London, pp 161–189Google Scholar
  54. Stanley M, Stanley B (1990) Postmortem evidence for serotonin's role in suicide. J Clin Psychiatry 51 [4, supp]: 22–28Google Scholar
  55. Stoff DM, Pollack L, Vetiello B et al. (1987) Reduction of [3H]-imipramine binding sites on platelets of conduct disordered children. Neuropsychopharmacology 1: 55–62Google Scholar
  56. Taylor SP (1967) Aggressive behaviour and physiological arousal as a function of provocation and the tendency to inhibit aggression. J Pers 35: 297–310Google Scholar
  57. Tiller JWG, Dakis JA, Shaw JM (1988) Short-term buspirone treatment in disinhibition with dementia. Lancet 2: 510Google Scholar
  58. Van Praag HM (1986) (Auto) Aggression and CSF 5-HIAA in depression and schizophrenia. Psychopharmacol Bull 22: 669–673Google Scholar
  59. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M (1987) Cerebrospinal fluid metabolites in male arsonists. Arch Gen Psychiatry 44: 241–247Google Scholar
  60. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bissette G, Kalogeras K, Karonen SL, Linnoila M (1994) CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholics, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 51: 20–27Google Scholar
  61. Volavka J, Crowner M, Brizer D, Convit A, Van Praag H, Suckow R (1990) Tryptophan treatment of aggressive inpatients. Biol Psychiatry 28: 728–732Google Scholar
  62. Young SN, Gauthier S (1981) Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 44: 323–327Google Scholar
  63. Young SN, Smith S, Pihl RO, Ervin FR (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87: 173–177Google Scholar
  64. Young SN, Pihl RO, Ervin FR (1988) The effect of altered tryptophan levels on mood and behaviour in normal human males. Clin Neuropharmacol 11 [suppl 1]: S207-S215Google Scholar
  65. Young SN, Ervin FR, Pihl RO, Finn P (1989) Biochemical aspects of tryptophan depletion in primates. Psychopharmacology 98: 508–511Google Scholar
  66. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361–370Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • A. J. Cleare
    • 1
  • A. J. Bond
    • 1
  1. 1.Institute of PsychiatryLondonUKI

Personalised recommendations